Use of a biomimetic strategy to engineer bone

Journal of Biomedical Materials Research - Part A

Volumn 65, Issue 4, 2003, Pages 447-453

  Holy, C E ^a   Fialkov, J A ^b   Davies, J E ^a,b   Shoichet, M S ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bone defect repair; Poly(lactic co glycolic acid); Regenerative medicine; Scaffold; Tissue engineering

Indexed keywords

BIOPOLYMERS; BONE; IMPLANTS (SURGICAL);

BONE-MARROW CELLS;

BIOMIMETIC MATERIALS;

POLYGLACTIN; BIOMATERIAL; LACTIC ACID; OSTEOCALCIN; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; BIOMIMETICS; BONE DEFECT; BONE MARROW CELL; BONE TISSUE; CONTROLLED STUDY; FRACTURE HEALING; GEOMETRY; MALE; MOUSE; NONHUMAN; OSSIFICATION; RABBIT; TISSUE ENGINEERING; TRABECULAR BONE; ANIMAL; BONE; BONE PROSTHESIS; BONE REGENERATION; CELL CULTURE; HUMAN; MATERIALS TESTING; METABOLISM; METHODOLOGY; MOLECULAR MIMICRY;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE AND BONES; BONE MARROW CELLS; BONE REGENERATION; BONE SUBSTITUTES; CELLS, CULTURED; FRACTURE HEALING; HUMANS; LACTIC ACID; MATERIALS TESTING; MOLECULAR MIMICRY; OSTEOCALCIN; POLYGLYCOLIC ACID; POLYMERS; RABBITS; TISSUE ENGINEERING;

EID: 0042469615     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.10453     Document Type: Article

References (30)

1. Whang K, Healy KE, Elenz DR, Nam EK, Tsai DC. Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture. Tissue Eng 1999;5:35-51.
2. Hollinger JO, Winn SR, Hu Y, Sipe R, Buck DC, Xi G. Assembling a bone-regeneration therapy. In: Davies JE, editor. Bone engineering. Toronto: em squared inc.; 2000. p 435-440.
3. Ishaug SL, Crane GM, Miller MJ, Yasko AW, Yaszemski MJ, Mikos AG. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 1997;36:17-28.
4. Crane GM, Ishaug SL, Mikos AG. Bone tissue engineering. Nature Med 1995;1:1322-1324.
5. Ishaug-Riley SL, Crane-Kruger GM, Yaszemski MJ, Mikos AG. Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials 1998;19:1405-1412.
6. Lewandrowski K-U, Cattaneo MV, Gresser JD, Wise DL, White RL, Bonassar L, Trantolo DJ. Effect of a poly(propylene fumarate) foaming cement on the healing of bone defects. Tissue Eng 1999;5:305-316.
7. Ohgushi H, Caplan A. Stem cell technology and bioceramics: From cell to gene engineering. J Biomed Mater Res, Appl Biomater 1999;48:913-927.
8. Baksh D, Kim SY, Davies JE. Three dimensional matrices of calcium polyphosphates support bone growth in vitro and in vivo. J Mater Sci: Mater Med 1998;9:743-748.
9. Holy CE, Shoichet MS, Davies JE. Bone marrow cell colonization of and extracellular matrix expression on biodegradable polymers. Cells and Mater 1997;7:223-234.
10. Holy CE, Dang SM, Davies JE, Shoichet MS. In vitro degradation of a novel poly (lactide-co-glycolide) 75/25 foam. Biomaterials 1999;20:1177-1185.
11. Holy CE, Shoichet MS, Davies JE. Engineering three-dimensional bone tissue in vitro using biodegradable scaffolds: Investigating initial cell-seeding density and culture period. J Biomed Mater Res 2000;51:376-382.
12. Holy CE, Cheng C, Davies JE, Shoichet MS. Optimizing the sterilization of PLGA scaffolds for use in tissue engineering. Biomaterials 2001;22:25-31.
13. Davies JE. In vitro modeling of the bone/implant interface. Anat Rec 1996;245:426-445.
14. Maniatopoulos C, Sodek J, Melcher AH. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 1988;254:317-330.
15. Rokkanen P, Nordstrom P, Pihlajamaki H, Toivonen T, Tormala P. Tissue response to polyglycolide and polylactide pins in cancellous bone. Arch Orthop Traumatol Surg 1998;117:197-204.
16. Rodan GA. Introduction to bone biology. Bone 1992;13:S3-S6.
17. Brighton CT, Hunt RM. Early histological and ultrastructural changes in medullary fracture callus. J Bone Joint Surg Am 1991;73:832-847.
18. Rout PGJ, Tarrant SF, Frame JW, Davies JE. Interaction between primary bone cell cultures and biomaterials. I. A comparison of dense and macroporous hydroxyapatite. In: Pizzoferrato A, Ravaglioli PG, Lee AJC, editors. Biomaterials and clinical applications. Amsterdam: Elsevier 1987;591-596.
19. Davies JE, Baksh D. Bone tissue engineering on biodegradable scaffolds. In: Tissue engineering for therapeutic use. IV. Ikada Y, Shimizu Y, editors. Amsterdam: Elsevier Science; 2000. p 15-24.
20. Baksh D, Davies JE. Design strategies for 3-dimensional in vitro bone growth in tissue-engineering scaffolds. In: Davies JE, editor. Bone engineering. Toronto: em squared Inc. 2000. p 488-495.
21. Klawitter JJ, Hulbert SF. Application of porous ceramics for the attachment of load-bearing orthopedic applications. J Biomed Mater Res Symp 1971;2:161-168.
22. Schugens C, Maquet V, Grandfils C, Jerome R, Teyssie P. Polylactide macroporous biodegradable implants for cell transplantation. II. Preparation of polylactide foams by liquid-liquid phase separation. J Biomed Mater Res 1996;30:449-461.
23. Davies JE, Chernecky R, Lowenberg B, Shiga A. Deposition and resorption of calcified matrix in vitro by rat bone marrow cells. Cells and Mater 1991;1:3-15.
24. Rodan GA, Martin TJ. Role of osteoblasts in hormonal control of bone resorption-A hypothesis. Calcif Tissue Int 1981;33:349-351.
25. Bellows CG, Aubin JE, Heersche JNM, Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. Endocrinology 1987;121: 1985-1992.
26. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV. Differentiation of human bone marrow osteogenic stromal cells in vitro: Induction of the osteoblast phenotype by dexamethasone. Endocrinology 1994;134:277-286.
27. Thiede MA, Smock SL, Petersen DN, Grasser WA, Thompson DD, Nishimoto SK. Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover in bone marrow megakaryocytes and peripheral blood platelets. Endocrinology 1994;135:929-937.
28. Lian JB, Stein GS. Concepts of osteoblast growth and differentiation: Basis for modulation of bone cell development and tissue formation. Crit Rev Oral Biol Med 1992;3:269-305.
29. Bradbeer JN, Zanelli JM, Lindsay PC, Pearson J, Reeve J. Relationship between the location of osteoblastic alkaline phosphatase activity and bone formation in human iliac crest bone. J Bone Miner Res 1992;7:905-912.
30. Chentoufi J, Hott M, Lamblin D, Buc-Caron MH, Marie PJ, Kellermann O. Kinetics of in vitro mineralization by an osteogenic clonal cell line (C1) derived from mouse teratocarcinoma. Differentiation 1993;53:181-189.